你即將離開本站

並前往https://eunethta.eu/wp-content/uploads/2020/08/EUnetHTA-Covid-19_RCR08_DEXAMETHASONE_August2020_FINAL.docx.pdf

Dexamethasone for the treatment of COVID-19 - EUnetHTA

NCT04325061. EudraCT 2020-. 001278-31. NCT04499313. Phase & Intention. Phase 2/3, to provide reliable estimates of the effect of study.

確定！ 回上一頁

查詢 「Nct04325061」的人也找了：